1. Begue S. La deleucocytation [in French]. Transfus Clin Biol. 1998;5:411-414.
2. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood. 1995;86:3598-3603.
3. Pamphilon DH, Foot ABM, Adeodu A. Prophylaxis and prevention of CMV infection in BM allograft recipients: leucodepleted platelets are equivalent to those from CMV seronegative donors [letter]. Bone Marrow Transplant. 1999;23:S66.
4. Sayers MH. Transfusion-transmitted viral infections other than hepatitis and human immunodeficiency virus infection, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, and human parvovirus B19. Arch Pathol Lab Med. 1994;118:346-349.
5. Dodd RY. Impact of leukodepletion on infections other than cytomegalovirus. Curr Stud Hematol Blood Transfus. 1994;(60):53-63.